OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
83 hedge funds and large institutions have $247M invested in OncoMed Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
5% less funds holding
Funds holding: 87 → 83 (-4)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Holders
83
Holding in Top 10
3
Calls
$3.19M
Puts
$2.16M
Top Buyers
| 1 | +$6.2M | |
| 2 | +$4.12M | |
| 3 | +$3.97M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.96M |
| 5 |
VAM
Visium Asset Management
New York
|
+$3.68M |
Top Sellers
| 1 | -$8.67M | |
| 2 | -$3.03M | |
| 3 | -$1.99M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.81M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.6M |